Informations sur le produit
Nom :
Gdc-0152
Description :
Gdc-0152 is a small molecule drug that inhibits the polymerase chain reaction (PCR) by binding to the enzyme DNA polymerase. Gdc-0152 targets human cells, inhibiting growth in tumor cell lines and in patients with bone cancer. It has been shown to suppress autophagy, which may have therapeutic benefits for cancer treatment. Gdc-0152 has also been shown to inhibit survivin, a protein that can stimulate tumor growth and metastasis. Gdc-0152 is currently being developed as an anticancer drug for use in humans.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
498.64 g/mol
Formule :
C25H34N6O3S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
